The PE Ratio as of December 2025 (TTM) for CERo Therapeutics Holdings, Inc. (CERO) is -0.02

According to CERo Therapeutics Holdings, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.02. This represents a change of -100.29% compared to the average of 6.89 of the last 4 quarters.

CERo Therapeutics Holdings, Inc. (CERO) Historical PE Ratio (quarterly & annually)

How has CERO PE Ratio performed in the past?

The mean historical PE Ratio of CERo Therapeutics Holdings, Inc. over the last ten years is -8399.82. The current -0.02 PE Ratio has changed -99.98% with respect to the historical average. Over the past ten years (40 quarters), CERO's PE Ratio was at its highest in in the September 2022 quarter at 6.86K. The PE Ratio was at its lowest in in the June 2021 quarter at -580756.05.

CERo Therapeutics Holdings, Inc. (CERO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of CERo Therapeutics Holdings, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

CERo Therapeutics Holdings, Inc. (CERO) Average PE Ratio

How has CERO PE Ratio performed in the past?

The current PE Ratio of CERo Therapeutics Holdings, Inc. (CERO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

CERo Therapeutics Holdings, Inc. (CERO) PE Ratio vs. Peers

How is CERO’s PE Ratio compared to its peers?

CERo Therapeutics Holdings, Inc.’s PE Ratio is greater than Liminatus Pharma, Inc. Class A Common Stock (-10.23), greater than XORTX Therapeutics Inc. (-1.29), less than Ocean Biomedical, Inc. (-0.00), greater than Galmed Pharmaceuticals Ltd. (-0.50), greater than NKGen Biotech, Inc. Common Stock (-0.03), greater than BioVie Inc. (-0.45), greater than PMGC Holdings Inc. (-0.64), greater than BriaCell Therapeutics Corp. Warrant (-2.29), greater than Moolec Science S.A. (-2.72), greater than Protagenic Therapeutics, Inc. (-0.36),

Build a custom stock screener for CERo Therapeutics Holdings, Inc. (CERO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CERo Therapeutics Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CERo Therapeutics Holdings, Inc. (CERO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CERo Therapeutics Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.